We evaluated the diagnostic performance of serum YKL-40 alone or in combination with the CEA, CYFRA21-1 and SCCA tumor markers for patients with esophageal squamous cell carcinoma (ESCC). This evidence concerns the gene CEACAM5 and esophageal squamous cell carcinoma.